Jubilant Pharmova Ltd - 530019 - Intimation Of Record Date
Intimation of Record Date for the purpose of Declaration of Dividend for the Financial Year 2022-2331-07-2023
Jubilant Pharmova Ltd - 530019 - Intimation Of Record Date
Intimation of Record Date for the purpose of Declaration of Dividend for the Financial Year 2022-23Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Postal Ballot Notice dated July 22, 2023Jubilant Pharmova Ltd - 530019 - Notice Of Postal Ballot
We enclose herewith the Notice of Postal Ballot dated July 20, 2023 that has been shared through e-mail to the shareholders of the Company today afternoon seeking their approval on the business items as contained in the notice.Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Financial Results for quarter ended June 30, 2023Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 (LODR)
Grant of 78,997 Stock OptionsJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for presentation of Q1 FY 2024 of Jubilant Pharmova LimitedJubilant Pharmova Q1 Results: Net profit at 6.4 crore; Revenue rises 9% YoY
Jubilant Pharmova Ltd's Q1 net profit falls 86.4% YoY to 6.4 crore, down from 47.1 crore in the same period last year. Shares down over 2%.Jubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 75(5) of SEBI (DP) Regulations, 2018Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of newspaper advertisements with respect to notice of transfer of equity shares of Company to Investor Education and Protection Fund (''IEPF'').